Christine Cassiano

Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL

APP Pharmaceuticals, Inc. develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. It offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. The company is headquartered in Los Angeles, CA.

Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA.

Hill+Knowlton Strategies LLC provide international communications consultancy services. It helps brands and the public communicate. The firm offers senior counsel, insightful research and strategic communications throughout the world. The company was founded in 1964 and is headquartered in New York, NY.

Part of Real Chemistry, Inc., ARC2 Communications & Media, Inc. provides healthcare communications agency services. The private company is based in Los Angeles, CA. The company was founded by Christine Cassiano. ARC2 Communications & Media was acquired by Real Chemistry, Inc. on February 18, 2015.

Real Chemistry, Inc. is an end-to-end healthcare experience group that leverages advanced AI-powered insights, diverse expertise, and customer-centric ideas to transform the healthcare industry. Real Chemistry is based in New York, NY and has subsidiaries in Canada, United Kingdom, and United States. The company helps healthcare professionals better understand, reach, and engage patients, while creating healthcare experiences that span diagnosis to adherence. The company was founded in 2001 by Jim Weiss. Shankar Narayanan has been the CEO of the company since 2022.